Decent returns expected from Biocon: Shrikant Chouhan

Shrikant Chouhan, Senior Vice President Technical Research, Kotak Securities in an interview with ET Now talks about midcap small cap pharma stocks.

Midcap small cap pharma has done very well in last 2 days. The results have been good by some of these. Do you like anything here?

There is action but we are looking for especially those stocks which are having very good volumes or they have decent history in the past. You can select Strides Arcolab but Surya Pharma and all, to time and to trade, it is very tough. If we are ready to select book at least 10% loss on our investments, then we can look for these stocks, otherwise Biocon, they are the real stocks in which we can expect further appreciation and we may expect rally of next 3 to 4 months and decent returns are always there.